Target intelligence / Profile preview

Heat shock protein beta-1 (HSPB1)

Target
HSPB1
Molecular classification
Small heat shock protein, Molecular chaperone, Protein folding chaperone, Other
01

Overview

Heat shock protein beta-1 is a small heat shock protein and molecular chaperone encoded by the HSPB1 gene. It is ubiquitously expressed in human tissues and helps maintain protein homeostasis by binding to and refolding denatured or misfolded proteins, especially under conditions of cellular stress such as heat, oxidative injury, or toxins. In neurons, it maintains axonal structure by organizing neurofilaments, supporting nerve impulse transmission. HSPB1 is involved in actin and cytoskeleton organization, muscle fiber contraction, and cellular migration. It acts as an inhibitor of apoptosis by interfering with pro-apoptotic signals and proteins. Mutations in the HSPB1 gene are linked to hereditary neuropathies such as Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Overexpression of HSPB1 is correlated with increased resistance to therapy and poor prognosis in several cancers, where it helps tumor cells evade stress-induced apoptosis and promotes metastasis.

Other names
28 kDa heat shock proteinEstrogen-regulated 24 kDa proteinHeat shock 27 kDa proteinHeat shock protein family B member 1HSP 27HSP27HSP28HspB1SRP27Stress-responsive protein 27
02

Mechanism of action

Drugs or experimental inhibitors often act as chaperone activity inhibitors, aggregation modulators, or modulators of apoptosis and stress responses

03

Biological functions

Protein foldingProtein refoldingPrevention of protein aggregationCytoskeleton stabilizationStress resistanceCell movementMuscle contractionApoptosis inhibitionRegulation of autophagyRegulation of protein phosphorylation
04

Disease associations

CancerCharcot-Marie-Tooth disease (Axonal, Type 2F)Distal hereditary motor neuropathy (type II)Neurodegenerative diseaseOther
05

Safety considerations

Safety concerns relate to potential off-target effects on cellular proteostasis, cytoskeleton, and stress responses, as inhibition may impair protein folding and cellular stress tolerance; high levels of HSPB1 may also contribute to tumor cell survival and resistance to apoptosis in cancer therapy
06

Interacting drugs

There are currently no major approved drugs that specifically target heat shock protein beta-1 (HSPB1/HSP27); however, some investigational compounds (e.g., HSP27 inhibitors) are under study in oncology and neuroprotection. Most direct drug interactions listed in public databases to date are experimental or related to high-throughput screening
07

Biomarkers

HSPB1 protein expression levels can serve as a biomarker for poor prognosis in several cancers and for some neurodegenerative and neuromuscular diseases

Beyond the preview

Go deeper on Heat shock protein beta-1 (HSPB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock protein beta-1 (HSPB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call